Human β-defensin 2 but not β-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease

Jan Wehkamp(Robert Bosch Hospital), Eduard F. Stange(John Radcliffe Hospital), M. Duchrow, Klaus Fellermann(Apple (Israel)), Bettina Schwind(University Gastroenterology), Klaus Herrlinger(Robert Bosch Hospital), Klaus J. Schmidt(University Gastroenterology), Steffi Baxmann(University Gastroenterology), Alfred C. Feller, Charlotte Wohlschläger(University of Lübeck)
European Journal of Gastroenterology & Hepatology
July 1, 2002
10.1097/00042737-200207000-00006
Cited by 200

Related Papers

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
|The Lancet Oncology|2015|613